Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

273 Views

Poster Session: HAI: C. difficile

397 - Oral Vancomycin Versus Fidaxomicin for Clostridiodes difficile: A Comparative Retrospective Evaluation across a Large, Multi-center Healthcare System

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Kaleb Roemer, PharmD

Manager, Clinical Pharmacy Services
HCA Healthcare
Nashville, Tennessee, United States

Co-Author(s)

HB

Hayley Burgess, PharmD, MBA, BCPP, CPPS

HCA Healthcare
Nashville, Tennessee, United States
KS

Kenneth E. Sands, MD, MPH

Chief Epidemiologist, HCA Healthcare
HCA Healthcare
Nashville, Tennessee, United States
RH

Ryan Hodgin, n/a

HCA Healthcare
Nashville, Tennessee, United States